I-Mab Biopharma
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics in the fields of immuno-oncology and immuno-inflammation diseases primarily in the United States. It is developing Uliledlimab, a CD73 neutralizing antibody, which is in Phase ...
I-Mab Biopharma Logo
About I-Mab Biopharma
I-Mab operates as a clinical stage biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of novel biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. I-Mab conducts business in the United States and China.
Address
2440 Research Boulevard, Suite 400
Rockville, 20850
United States
Year founded
1970
Number of employees
200-300
Report inaccurate data
Request an update to help us keep the brand up-to-date.
